These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 14515149)

  • 21. Effects of peroxisome proliferator-activated receptor gamma ligands ciglitazone and 15-deoxy-delta 12,14-prostaglandin J2 on rat cultured cerebellar granule neuronal viability.
    Smith SA; Monteith GR; Holman NA; Robinson JA; May FJ; Roberts-Thomson SJ
    J Neurosci Res; 2003 Jun; 72(6):747-55. PubMed ID: 12774315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cyclopentenone-type prostaglandin 15-deoxy-delta 12,14-prostaglandin J2 inhibits CD95 ligand gene expression in T lymphocytes: interference with promoter activation via peroxisome proliferator-activated receptor-gamma-independent mechanisms.
    Cippitelli M; Fionda C; Di Bona D; Lupo A; Piccoli M; Frati L; Santoni A
    J Immunol; 2003 May; 170(9):4578-92. PubMed ID: 12707336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peroxisome proliferator activator receptor-gamma ligands, 15-deoxy-Delta(12,14)-prostaglandin J2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathways.
    Zingarelli B; Sheehan M; Hake PW; O'Connor M; Denenberg A; Cook JA
    J Immunol; 2003 Dec; 171(12):6827-37. PubMed ID: 14662889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PPAR-gamma ligands modulate effects of LPS in stimulated rat synovial fibroblasts.
    Simonin MA; Bordji K; Boyault S; Bianchi A; Gouze E; Bécuwe P; Dauça M; Netter P; Terlain B
    Am J Physiol Cell Physiol; 2002 Jan; 282(1):C125-33. PubMed ID: 11742805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 15-Deoxy-delta(12,14)-prostaglandin J(2) inhibits IL-1beta-induced IKK enzymatic activity and IkappaBalpha degradation in rat chondrocytes through a PPARgamma-independent pathway.
    Boyault S; Bianchi A; Moulin D; Morin S; Francois M; Netter P; Terlain B; Bordji K
    FEBS Lett; 2004 Aug; 572(1-3):33-40. PubMed ID: 15304320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostaglandin J2 metabolites inhibit aromatase activity by redox-sensitive mechanisms: potential implications for breast cancer therapy.
    Winnett G; van Hagen D; Schrey M
    Int J Cancer; 2003 Feb; 103(5):600-5. PubMed ID: 12494466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peroxisome proliferator-activated receptor gamma is required for the inhibitory effect of ciglitazone but not 15-deoxy-Delta 12,14-prostaglandin J2 on the NFkappaB pathway in human endothelial cells.
    Kaplan J; Cook JA; O'Connor M; Zingarelli B
    Shock; 2007 Dec; 28(6):722-726. PubMed ID: 17621259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 15-Deoxy-Delta(12,14)-prostaglandin J(2) and troglitazone regulation of the release of phospholipid metabolites, inflammatory cytokines and proteases from human gestational tissues.
    Lappas M; Permezel M; Rice GE
    Placenta; 2006; 27(11-12):1060-72. PubMed ID: 16434095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 15-Deoxy-Delta(12,14)-prostaglandin J2 inhibits the expression of proinflammatory genes in human blood monocytes via a PPAR-gamma-independent mechanism.
    Hinz B; Brune K; Pahl A
    Biochem Biophys Res Commun; 2003 Mar; 302(2):415-20. PubMed ID: 12604364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of cellular proliferation through IkappaB kinase-independent and peroxisome proliferator-activated receptor gamma-dependent repression of cyclin D1.
    Wang C; Fu M; D'Amico M; Albanese C; Zhou JN; Brownlee M; Lisanti MP; Chatterjee VK; Lazar MA; Pestell RG
    Mol Cell Biol; 2001 May; 21(9):3057-70. PubMed ID: 11287611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peroxisome proliferator--activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes.
    Fahmi H; Di Battista JA; Pelletier JP; Mineau F; Ranger P; Martel-Pelletier J
    Arthritis Rheum; 2001 Mar; 44(3):595-607. PubMed ID: 11263774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peroxisome proliferator-activated receptor-gamma ligands inhibit nitric oxide synthesis in vascular smooth muscle cells.
    Ikeda U; Shimpo M; Murakami Y; Shimada K
    Hypertension; 2000 Jun; 35(6):1232-6. PubMed ID: 10856269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells.
    Hashimoto K; Ethridge RT; Evers BM
    Int J Gastrointest Cancer; 2002; 32(1):7-22. PubMed ID: 12630765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 15-Deoxy-prostaglandin J(2) inhibits PDGF-A and -B chain expression in human vascular endothelial cells independent of PPAR gamma.
    Zhang J; Fu M; Zhao L; Chen YE
    Biochem Biophys Res Commun; 2002 Oct; 298(1):128-32. PubMed ID: 12379230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peroxisome proliferator-activated receptor gamma ligands differentially modulate muscle cell differentiation and MyoD gene expression via peroxisome proliferator-activated receptor gamma -dependent and -independent pathways.
    Hunter JG; van Delft MF; Rachubinski RA; Capone JP
    J Biol Chem; 2001 Oct; 276(41):38297-306. PubMed ID: 11477074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of apoptosis by 15d-PGJ2 via ROS formation: an alternative pathway without PPARγ activation in non-small cell lung carcinoma A549 cells.
    Wang JJ; Mak OT
    Prostaglandins Other Lipid Mediat; 2011 Apr; 94(3-4):104-11. PubMed ID: 21396480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits angiotensin II-induced fibronectin expression via hepatocyte growth factor induction in human peritoneal mesothelial cells.
    Yokoyama Y; Masaki T; Kiribayashi K; Nakashima A; Kokoroishi K; Ogawa T; Kohno N; Yorioka N
    Ther Apher Dial; 2010 Feb; 14(1):43-51. PubMed ID: 20438519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 15-Deoxy-delta12,14-prostaglandin J2-glycerol ester, a putative metabolite of 2-arachidonyl glycerol, activates peroxisome proliferator activated receptor gamma.
    Raman P; Kaplan BL; Thompson JT; Vanden Heuvel JP; Kaminski NE
    Mol Pharmacol; 2011 Jul; 80(1):201-9. PubMed ID: 21511917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism.
    Farrajota K; Cheng S; Martel-Pelletier J; Afif H; Pelletier JP; Li X; Ranger P; Fahmi H
    Arthritis Rheum; 2005 Jan; 52(1):94-104. PubMed ID: 15641079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 15-Deoxy-delta(12,14) prostaglandin J2: a putative endogenous promoter of adipogenesis suppresses the ob gene.
    Sinha D; Addya S; Murer E; Boden G
    Metabolism; 1999 Jun; 48(6):786-91. PubMed ID: 10381155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.